Stocks Health care MBIO
NASDAQ · Health careMustang Bio, Inc. (MBIO)
It posted a net loss of $3M. At June 30, 2026 it held $15.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Mustang Bio, Inc.
- Net worth
- Mustang Bio, Inc. has a market value (market cap) of $3.3M at the latest share price, and shareholders' equity of $7.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $5.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Mustang Bio, Inc.'s next report was expected around November 6, 2026 and is not on file with the SEC yet.
What Mustang Bio, Inc. does
Mustang Bio, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MBIO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$1.9M | -$0.39 | n/a |
| 2024 | n/a | -$15.8M | -$38.57 | -$11.4M |
| 2023 | n/a | -$51.6M | -$299.95 | -$49.5M |
| 2022 | n/a | -$77.5M | -$504.42 | -$67.8M |
| 2021 | n/a | -$66.4M | -$511.14 | -$57.7M |
| 2020 | n/a | -$60M | -$766.71 | -$39.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Mustang Bio, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 5, 2026
- May 5, 2026
- April 17, 2026
- March 19, 2026
- December 23, 2025
- December 3, 2025Proxy statement DEF 14A
- November 7, 2025
- August 12, 2025Passive stake changed SCHEDULE 13G/A
- August 8, 2025
- July 9, 2025Other event 8-K
Insider trades
What the people running Mustang Bio, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| April 24, 2026 | Litchman Manuel MDPresident, CEO and Interim CFO, Director | Shares withheld for tax | 19 | $14.3 |
| December 30, 2025 | Jin DavidDirector | Bought | 247 | $237.6 |
| December 30, 2025 | Chill Adam J.Director | Sold | 4 | $3.8 |
| December 30, 2025 | Herskowitz NeilDirector | Sold | 247 | $237.6 |
Who owns MBIO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
4 insiders reported holding 2,421 shares in total, about $1.1K at the last price.
| Holder | Shares |
|---|---|
| Litchman Manuel MDPresident, CEO and Interim CFO, Director | 1,615 |
| Chill Adam J.Director | 375 |
| Jin DavidDirector | 286 |
| Herskowitz NeilDirector | 145 |
Questions about MBIO
What does Mustang Bio, Inc. do?
Mustang Bio, Inc. is a company in the Health care sector, listed on NASDAQ as MBIO. Its shares trade on NASDAQ under the ticker MBIO.
What is Mustang Bio, Inc.'s net worth?
Mustang Bio, Inc. has a market value (market cap) of $3.3M at the latest share price, and shareholders' equity of $7.5M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Mustang Bio, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3M.
When did Mustang Bio, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026.
When is Mustang Bio, Inc.'s next earnings report?
Mustang Bio, Inc.'s next report was expected around November 6, 2026 and is not on file with the SEC yet.
Similar companies
Compare MBIO with
Follow MBIO
Get an email when Mustang Bio, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Mustang Bio, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.